Similarly, solasonine has been reported to inhibit the glucose metabolism via the suppression of β-catenin/Wnt signaling [12], whereas cryptotanshinone has been shown to reduce glycolysis via PKM2/β-catenin in breast cancer [13]. The gene discussed is PKM; the disease is breast carcinoma.